|

Pembrolizumab + Enfortumab Vedotin Clinical Trials

1 actively recruiting trial

Also known as: KEYTRUDA + PADCEV

Pipeline

Phase 2: 1

Top Sponsors

  • Giuseppe Procopio1

Indications

  • Renal Medullary Carcinoma1
  • Collecting Duct Carcinoma1
  • Bellini Carcinoma1
  • Cancer1

Other1 trial

Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.